Benefit from LCT in oligometastatic NSCLC
- PMID: 31123347
- DOI: 10.1038/s41571-019-0233-1
Benefit from LCT in oligometastatic NSCLC
Comment on
-
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.J Clin Oncol. 2019 Jun 20;37(18):1558-1565. doi: 10.1200/JCO.19.00201. Epub 2019 May 8. J Clin Oncol. 2019. PMID: 31067138 Free PMC article. Clinical Trial.
References
Original article
-
- Gomez, D. R. et al. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J. Clin. Oncol. https://doi.org/10.1200/JCO.19.00201 (2019) - DOI - PubMed
Further reading
-
- Gomez, D. R. et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 17, 1672–1682 (2016) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical